Search results
The University of Miami to Pay $22 Million to Settle Medicare False Claims Act Allegations
The National Law Review· 2 weeks agoAllegations were first raised in 2013 through the filing of a whistleblower lawsuit.
Regeneron (REGN) Accused of Fraudulent Practices Related to Eylea
Zacks via Yahoo Finance· 2 weeks agoThe lawsuit was originally filed under the qui tam or whistleblower provisions of the FCA. Eylea is...
JD Supra: Medicare Advantage: Managed Care Compliance in 2024
JD Supra· 5 days agoMedicare & Medicaid Services (CMS) for reimbursement through its Medicare Administrative Contractors. Conversely, Part C (also referred to as Medicare ...
US DOJ files false claims complaint against Regeneron for alleged Medicare reimbursement fraud
Lohud | The Journal News via Yahoo Finance· 2 weeks agoThe U.S. Department of Justice said it filed a claim against NY-based Regeneron for allegedly falsely inflating Medicare reimbursement rates for a product.
Clinicas faces more accusations of retaliation in new whistleblower lawsuit
VC Star | Ventura County Star via Yahoo Finance· 3 days agoClinicas officials did not respond...Alatorre's lawsuit but have previously denied allegations made...
A Guide for a False Claims Act Whistleblower
The National Law Review· 7 days agoThe federal False Claims Act is a favorite of whistleblowers because it provides broad workplace protections against retaliation and some of the most...
DOJ files complaint against Regeneron over Eylea Medicare pricing (NASDAQ:REGN)
Seeking Alpha· 2 weeks agoThe DOJ has filed a complaint against Regeneron (REGN) alleging the drugmaker fraudulently inflated ...
A Guide for Whistleblowers Under the False Claims Act | JD Supra
JD Supra· 1 week agowhistleblower law. For whistleblowers, the False Claims Act is generally the best way to proceed with their case, as it provides them with workplace protections ...
Nick Ladin-Sienne
The National Law Review· 6 days agoIn advising clients, Nick provides efficient and effective answers to legal questions and guidance on risk management. Whether it’s an employee making a ...
DOJ Files Second Qui Tam Lawsuit Against Regeneron Pharmaceuticals
The National Law Review· 1 week agoThe United States announced that it has intervened in a False Claims Act case against New York-based Regeneron Pharmaceuticals Inc. (Regeneron). The suit, brought by two whistleblowers ...
